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BACKGROUND: The aim of this bench study was to investigate the performances of 8 devices for
noninvasive CPAP. METHODS: Eight devices for noninvasive CPAP with an orofacial mask were
studied: Ventumask, Ventumask 30, EasyVent, EasyVent Emergency, Compact Model II, Flowone,
Superflow, Boussignac CPAP valve. Each device was tested at oxygen input flows from 5 to 20
L/min, and the output gas flow was measured in static conditions. Each device was evaluated during
a eupneic and a tachypneic simulated breathing test. RESULTS: The gas output flow generated by
each device increased with higher oxygen input flow; EasyVent and Flowone produced the highest
output flow (P< .001). At the simulated eupneic breathing test, Superflow and EasyVent showed a more
stable pressure swing at different PEEP levels, whereas the other masks had a greater swing, between
10 and 15 cm H2O PEEP (P .002 for all pairwise comparisons). During the tachypneic breathing test,
the pressure swing was stable with Flowone and EasyVent (P  .055), whereas it had increased with
other masks (P .002 for all pairwise comparisons). CONCLUSIONS: We found a significant variation
in the performances of the 8 CPAP devices examined in this study. The technical characteristics and
limitations of different CPAP devices should be considered when using in patients with hypoxemic acute
respiratory failure. Key words: CPAP; mechanical ventilation; respiratory failure; hypoxemia; orofacial
mask; effectiveness; efficacy. [Respir Care 0;0(0):1–•. © 0 Daedalus Enterprises]
Introduction
Noninvasive CPAP is a widely used ventilation tech-
nique to improve oxygenation.1,2 CPAP devices provide a
specific level of positive pressure during the respiratory
cycle to prevent alveolar collapse and increase lung vol-
ume.3 Recently, several devices for short-term use have
been made available; these are capable of delivering CPAP
at different pressure levels while only requiring a gas source
to be operated. These devices are ideal for use in settings
such as extra-hospital or intra-hospital emergencies, which
allows positive-pressure respiratory assistance in patients
who are not intubated.4 The level of CPAP is determined
in most devices by an adjustable or fixed PEEP valve, and
the total gas flow is essential to ensure a stable pressure level
throughout the respiratory cycle,3 with a minimum flow of
60 L/min generally required in patients with an increased
respiratory demand.4 This study compared 8 devices for non-
invasive CPAP with an orofacial mask. Seven devices used
the Venturi effect to generate flow: Ventumask (Starmed,
Mirandola, Italy), Ventumask 30 (Starmed), EasyVent (Di-
mar, Mirandola, Italy), EasyVent Emergency (Dimar),
Compact Model II (Harol, San Donato Milanese, Italy);
Flowone (Deas, Castelbolognese, Italy), and Superflow
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(Deas). One device, the Boussignac CPAP valve (Vygon,
Ecouen, France), used the Bernoulli principle with a vir-
tual valve effect.3
The aim of this study was to investigate the perfor-
mances of these 8 CPAP devices in terms of effectiveness,
defined as evaluation of output flow generation in static
conditions, and of efficacy, defined as airway pressure
swing, namely the difference between inspiratory and ex-
piratory pressures during simulated spontaneous breathing
with eupneic and tachypneic respiratory patterns. We hy-
pothesized that the effectiveness and efficacy were differ-
ent in the tested devices. The work was performed at the
University of Naples Federico II, Naples, Italy.
Methods
Devices
Eight devices for noninvasive CPAP with orofacial
mask were studied (Fig. 1): Ventumask, Ventumask 30,
EasyVent, EasyVent Emergency, Compact Model II,
Flowone, Superflow, and Boussignac CPAP valve. These
devices operate with a single external oxygen source, and
some also have an additional oxygen source, located down-
stream from the air-entrainment valve, that may be used to
increase FIO2. The characteristics of the masks evaluated in
the present study are shown in Table 1. The Boussignac
CPAP valve system is the only commercially available de-
vice that does not incorporate an air-entrainment Venturi sys-
tem: this device consists of a small cylinder that, when re-
ceiving the oxygen, the flow generates a turbulence, which
thus acts as a virtual PEEP valve and results in a positive
airway pressure. All other CPAP systems use the Venturi
effect to entrain room air and generate a high output flow,
and an adjustable or calibrated mechanical PEEP valve is
used to set the desired positive pressure level.
Experimental Setting
Output Flow Generation. An oxygen source was con-
nected to the devices and a flow meter, which measures the
air flow generated by the CPAP device, was positioned down-
stream from the air-entrainment valve. A rapid response ox-
ygen analyzer (MaxO2AE; Maxtec, Salt Lake City, Utah)
was placed at the side port of the devices to evaluate the
delivered FIO2. Each device was tested at increasingly higher
oxygen source flows, from 5 L/min up to 20 L/min in 4 steps.
The primary outcome was the output-flow generation (effec-
tiveness) of the different CPAP devices; the secondary out-
come was the airway inspiratory-expiratory pressure swing
(efficacy) during simulated spontaneous eupneic and tachy-
pneic respiratory patterns. Pressure swing (p) was defined
as the difference between inspiratory and expiratory airway
pressure around the CPAP level and was considered as an
indicator of the work of breathing.2
Static Test. Each mask was evaluated at 4 increasing
levels of PEEP (5, 10, 15, and 20 cm H2O) obtained with
adjustable valves and a pressure manometer that measured
the actual pressure inside the device. Each device was eval-
uated for generated output flow with a flow meter analyzer
(Fluke Biomedical, Cleveland, Ohio), FIO2 and with pressure
that started from 5 L/min of oxygen to 20 L/min, according
to the recommendations of the manufacturer.
Simulated Breathing Test. Each device was evaluated
during simulated spontaneous breathing by using a lung
model (Deas). Each mask was connected to a pneumatic
lung simulator with a preset respiratory frequency, volume
and inspiratory-expiratory ratio while generating a sinusoidal
flow. A pressure transducer, FIO2 analyzer, and flow analyzer
were serially connected. Two breathing patterns were inves-
tigated: (1) eupneic breathing with a volume of 500 mL, rate
of 20 breaths/min, minute volume of 10 L/min, and inspira-
tory-expiratory ratio 1:2; (2) tachypneic breathing with vol-
ume size of 800 mL, rate of 30 breaths/min, minute volume
of 24 L/min, and inspiratory-expiratory ratio 1:1. Each device
was tested for 2 min of uninterrupted simulated breathing.
Statistical Analysis
Data were reported as mean  SD. All data were ana-
lyzed by averaging 3 replicates from each experiment.
Normality was assessed with the D’Agostino-Pearson om-
nibus test. The total gas flow generated by different de-
vices was compared with a 2-way analysis of variance.
QUICK LOOK
Current knowledge
Noninvasive CPAP is the most commonly used venti-
lation technique in prehospital and emergency settings;
its benefits in patients with hypoxemic acute respiratory
failure are well known.
What this paper contributes to our knowledge
The results of the static and dynamic tests performed
indicated that the Dimar and Deas devices showed the
best performance in terms of output flow generation
and pressure swing around the imposed PEEP level
compared with the Starmed, Harol, and Boussignac
CPAP devices. The characteristics and the limitations
of different CPAP devices should be considered when
used in patients with hypoxemic acute respiratory failure.
CPAP PERFORMANCE WITH ORONASAL MASK
2 RESPIRATORY CARE • ● ● VOL ● NO ●
RESPIRATORY CARE Paper in Press. Published on May 29, 2018 as DOI: 10.4187/respcare.05930 
Copyright (C) 2018 Daedalus Enterprises ePub ahead of print papers have been peer-reviewed, accepted for publication, copy edited 
and proofread. However, this version may differ from the final published version in the online and print editions of RESPIRATORY CARE
The relationship between the oxygen input flow and gen-
erated air-flow output of each device was investigated with
a linear regression analysis. Pressures obtained at the static
and dynamic tests were compared by using the Kruskal-
Wallis test with Dunn post hoc analysis. All statistical
analyses were performed by using SPSS version 21 (IBM,
Armonk, New York), and significant at P  .05.
Results
Output Flow Generation
The gas output flow generated by each device increased
with higher O2 flow input (Fig. 1). The results of the linear
regression are reported in Table 2. The Dimar EasyVent
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Fig. 1. Output flow generated by each device according the O2 input flow.
Table 1. Characteristics of Different CPAP Devices Included in the Study
Device VenturiDevice
Concentration
of O2 (%)*
Feed With
Flow A  Flow B
Maximum Flow
Delivered (L/min)†
Adjustable
PEEP Valve
PEEP
Level (cm H2O)
Easy Vent  33–100  120  5, 10, 15, 20
Easy Vent Emergency  33 – (only flow A) 120  5, 10, 15, 20
Ventumask  40, 50, 60, 100 (with a
minimum O2 flow of
42 L/min)
 60  5, 7.5, 10, 12.5
Ventumask 30  30, 40, 50, 60, 100 (with
a minimum O2 flow of
40 L/min)
 80  5, 7.5, 10, 12.5, 15, 20
Flowone  30  122 –
Superflow  30–60  122 L/min  5, 10, 15, 20
Compact Model II  40–70  77 L/min  5, 10, 15
Boussignac – 30, 50, 100 – NA – 2, 4, 5, 7, 10 (according
to the delivered flow)
* Concentration of O2 approximately reached.
† As declared by the manufacturer.
NA  not applicable
  present
  absent
Flow A  Main flow
Flow B  Adjunctive flow
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and Deas Flowone produced the greatest output flow at
each O2 input flow compared with the other devices (Dimar
Easy Vent output flow generation 5, 10, 15, and 20 L/min
input flow: 65.6, 8.71, 90.6, 110.9, and 132.1 L/min. Deas
Flowone output flow generation 5, 10, 15, and 20 L/min
input flow: 63.7, 80.5, 86.4, 107.1, and 125.7 L/min).
Static Test
The masks evaluated at 4 levels of PEEP (5, 10, 15, and
20 cm H2O) with oxygen input flow of 20 L/min are
shown in Figure 2. At 20 L/min, the Dimar EasyVent and
Deas Flowone generated the highest output flow at each
PEEP level (output flows at each PEEP level of Dimar
EasyVent vs Deas Flowone, P .99), even if Deas Flowone
output flow decreased at 40 L/min with 20 cm H2O of
PEEP level. The Deas Flowone had the highest increase of
FIO2 at 15 and 20 cm H2O of PEEP (FIO2 39.3% and 55%,
respectively). The performances of all the masks evaluated
at 4 levels of PEEP (5, 10, 15, and 20 cm H2O) with
oxygen source flows of 10 and 30 L/min are shown in the
supplementary materials (see http://www.rcjournal.com).
Simulated Breathing Test
The airway pressure swing (p) during simulation of
eupneic and tachypneic breathing patterns is shown in Fig-
ure 3. During the eupneic breathing pattern test, the Deas
Superflow and Dimar EasyVent showed a more stable p
at different PEEP levels (Deas Superflow p: 2.38, 2.98,
and 4.33 cm H2O; and Dimar EasyVent p: 2.80, 3.03,
4.03, and 3.68 cm H2O at 5, 10, 15 and 20 cm H2O PEEP,
respectively), whereas the other masks had a greater swing
between 10 and 15 cm H2O of PEEP (Dimar EasyVent
Emergency p: 9.9 and 7.3 cm H2O; Starmed Ventumask
p: 6.6 and 4.3 cm H2O; Starmed Ventumask 30 p: 3.9
and 6.1 cm H2O; Deas Flowone p: 4.3 and 2.9 cm H2O;
Harol Compact Model II p: 6.3 and 7 cm H2O; Vygon
Boussignac p: 0.8 and 1.1 cm H2O at 5, 10, 15, and
20 cm H2O PEEP, respectively) (P  .002 for all pairwise
comparisons).
With the tachypneic breathing pattern test, p was sta-
ble between the Deas Flowone and Dimar EasyVent (Deas
Flowone p: 13.7, 14.8, 14.7, and 16.6 cm H2O; and Di-
mar EasyVent p: 6.3, 7.1, 7.9, and 10.8 cm H2O at 5, 10,
15, and 20 cm H2O PEEP, respectively) (P  .055 for all
pairwise comparisons), whereas p increased with other
masks (P  .001 for all pairwise comparisons). The in-
spiratory and expiratory pressures during eupneic and
tachypneic breathing pattern simulations are shown in the
supplementary materials (see http://www.rcjournal.com).
During the eupneic breathing pattern test, Flowone had the
highest inspiratory pressure than the other devices (Deas
Flowone inspiratory pressure: 3.3, 7.2, 11.4, and 13.9 cm
H2O at 5, 10, 15, and 20 cm H2O PEEP, respectively)
(P  .001 for all paired comparison), whereas, with
tachypnea breathing, the Deas Flowone and Dimar
EasyVent Emergency had the highest inspiratory pressure
Deas Flowone inspiratory pressure: 1.1, 5.5, 9.2, and 14.7 cm
H2O; and Dimar EasyVent Emergency inspiratory pressure:
12.4, 15.5, 16.8, and 16.6 cm H2O at 5, 10, 15, and 20 cm
H2O PEEP, respectively) (P  .001 for all paired compari-
son). The expiratory pressures were not different during both
breathing pattern simulations.
Discussion
Main Findings
In this bench study, we found that (1) the capability to
deliver an adequate output flow was different among the
CPAP devices, and (2) the devices showed different per-
formances in eupneic and tachypneic simulated breathing
conditions. CPAP devices are compact and easy-to-use
systems5 that have been shown to delay or avoid intuba-
tion in acute respiratory failure due to cardiac and non-
cardiac conditions, in both prehospital and hospital set-
tings.5,6 A recent meta-analysis that included 8 randomized
trials showed that the prehospital use of CPAP reduced
mortality and the risk for intubation compared with stan-
dard care, whereas the effectiveness of prehospital bi-level
inspiratory positive airway pressure was uncertain.7,8
From this perspective, CPAP may play a major role for
the treatment of acute respiratory failure.4,7 Because dif-
ferent CPAP devices have recently been marketed, it is
important for the medical staff to know the individual
performance of different brands, and thus identify the best
tools to be applied in specific populations of patients. The
strength of our study was that, to our knowledge, this was
the first bench comparison of the effectiveness and effi-
cacy of 8 different CPAP devices, including the Boussig-
nac system. The Boussignac system is the most studied
Table 2. Output Flow Generation Performance of Each Tested
Device
Device Slope (95% CI) Intercept r2
Easy Vent 0.219–0.238 10.4 0.99
Ventumask 0.292–0.306 7.6 0.99
Ventumask 30 0.334–0.418 16.3 0.98
Flowone 0.231–0.259 11.1 0.99
Superflow 0.331–0.456 9.4 0.98
Easy Vent Emergency 0.357–0.435 19 0.98
Compact Model II 0.27–0.3 5.6 0.99
Boussignac 0.287–0.293 0.008 1
Results are from the linear regression of the output flow generated vs the input flow.
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CPAP device.3 There is limited literature that compares
different devices based on the Venturi system. One study
compared 3 CPAP masks,9 whereas our study evaluated 8
devices.
In the present study, the efficiency of the devices was
compared based on oxygen flow needed to generate a
minimum air flow of 60 L/min at each CPAP setting,
generally required in patients with an increased respiratory
demand.4,8 In this study, the Dimar EasyVent and Deas
Flowone generated an output flow of 60 L/min with 5 L/min
of O2 input flow and an output flow of 120 L/min with
20 L/min of input flow. Probably because of the differ-
ent experimental setting, these results are slightly dif-
ferent from those reported by Brusasco et al9 in which
the Dimar EasyVent generated an output flow of60 L/min
with 5 L/min of O2 input flow.
The static test aimed to evaluate the performances of the
devices in developing adequate output flow by using the
Venturi system; the generated flow linearly decreased,
whereas FIO2 increased at higher PEEP.10 According to
Brusasco et al9, at increased PEEP levels, from 5 to 20 cm
H2O at 15 L/min of O2 input flow, the O2 output flow of
the Starmed devices dramatically decreased, and FIO2
increased up to 45%, whereas the Dimar EasyVent mask
kept a stable FIO2 of 40%, with a decreasing O2 output
flow.9
The devices were tested with 10, 20, 30 L/min of O2
input flow and CPAP levels from 5 to 20 cm H2O. Inter-
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Fig. 2. Static test for each device performed with 4 levels of PEEP (5, 10, 15, and 20 cm H2O) with oxygen source flows of 20 L/min. (A)
Easy Vent. (B) Flowone. (C) Compact II. (D) Boussignac. (E) Ventumask 30. (F) Ventumask.
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estingly, at 10 L/min of O2 input flow, we found that all
devices, except the Boussignac system, markedly decreased
the output flow, from 60 to 20 L/min. At 20 L/min, only
the Dimar devices and the Starmed Ventumask kept the O2
output flow of 60 L/min for all PEEP, whereas the Deas
Flowone kept the O2 output flow at 60 L/min only with
PEEP of 15 cm H2O.
Clinical Implications
A good CPAP device should maintain constant positive
pressure during the respiratory cycle to be able to reduce
the work of breathing.10 The respiratory muscles activity
during CPAP results in fluctuations in the airway pressure
around the imposed PEEP level, therefore, a greater pres-
sure swing is associated with increased respiratory effort.11
Moreover, the additional work of breathing may induce
respiratory muscle fatigue and discomfort in patients with
acute respiratory failure.12 With regard to these premises,
the majority of devices included in this study may not
adequately assist patients because these devices showed a
huge fluctuation of the airway pressures around the im-
posed PEEP level. During the eupneic and tachypneic
breathing pattern simulations, the Dimar Easyvent, Deas
Flowone, and Superflow showed the lowest pressure swing
around the imposed PEEP level, which suggested a better
ability to reduce the work of breathing. However, these
results should be confirmed in clinical studies.
CPAP devices are mainly used in patients with acute
respiratory failure and respiratory distress. The inspira-
tory pressure of the CPAP devices, according to our
results in physiologic breathing simulation, was always
above zero. Even during the stressful breathing test, 3
devices (Harol Compact Model II, Starmed Ventumask,
and Boussignac) showed an inspiratory pressure of less
than zero. A positive pressure maintained during the
inspiratory phase may decrease the inspiratory effort
and, thus, the work of breathing in patients with acute
respiratory failure.13
Limitations
Our findings should be interpreted in the context of
several limitations. First, this was an in vitro study, thus
clinical studies are needed to confirm our results. Second,
during breath simulation, we chose only 2 breathing
patterns, which did not reproduce the broad spectrum of
clinical conditions that can affect patients. Third,
Starmed and Harol masks are now available in North
America, Australia, and New Zealand, whereas Dimar
and Deas masks were only recently introduced in the
market. Fourth, the Deas Superflow, with the same char-
acteristics of Deas Flowone but with the addition of a
PEEP valve, was evaluated only in the breathing sim-
ulation tests.
Conclusions
As a result of the static and dynamic tests performed, we
found a relevant variation in the effectiveness and efficacy
of the 8 CPAP devices included in this study. The Dimar
and Deas devices showed the best performance in terms of
output flow generation and pressure swing around the im-
posed PEEP level compared with Starmed, Harol, and Bous-
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signac CPAP devices. The characteristics and limitations
of different CPAP devices should be considered when used
in patients with acute respiratory failure.
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